Versant Venture Capital VI, L.P.

LAVA Therapeutics N.V. · 10% Owner

Versant Venture Capital VI, L.P. is listed in filings as 10% Owner at LAVA Therapeutics N.V.. This profile follows SEC Form 4 activity through Oct 2, 2025, including sale activity. Recent filings connect the profile to LAVA Therapeutics N.V. (LVTX), LENZ Therapeutics, Inc. (LENZ), and Monte Rosa Therapeutics, Inc. (GLUE). The current snapshot covers public activity from Sep 13, 2024 to Oct 2, 2025. Reported amounts are shown as $329.9K to $294.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
LAVA Therapeutics N.V.LVTX$330k228.8k sharesSellSep 18, 2025$1.44$1.74
LAVA Therapeutics N.V.LVTX$338k226.7k sharesSellSep 17, 2025$1.49$1.74
LAVA Therapeutics N.V.LVTX$295k192.3k sharesSellSep 16, 2025$1.53$1.74
LAVA Therapeutics N.V.LVTX$528k366.1k sharesSellSep 18, 2025$1.44$1.74
LAVA Therapeutics N.V.LVTX$540k362.8k sharesSellSep 17, 2025$1.49$1.74
LAVA Therapeutics N.V.LVTX$472k307.7k sharesSellSep 16, 2025$1.53$1.74
LAVA Therapeutics N.V.LVTX$747k532.9k sharesSellSep 19, 2025$1.40$1.74
LENZ Therapeutics, Inc.LENZ$10M350k sharesSellJun 10, 2025$29.00$4.88
LENZ Therapeutics, Inc.LENZ$3M100.9k sharesSellJun 20, 2025$30.35$4.88
LENZ Therapeutics, Inc.LENZ$3M100k sharesSellJun 18, 2025$29.95$4.88
LENZ Therapeutics, Inc.LENZ$4M133.9k sharesSellJun 20, 2025$30.25$4.88
LENZ Therapeutics, Inc.LENZ$6M200k sharesSellJun 27, 2025$30.47$4.88
LENZ Therapeutics, Inc.LENZ$7M191.4k sharesSellJul 10, 2025$34.00$4.88
LENZ Therapeutics, Inc.LENZ$582k15.1k sharesSellAug 18, 2025$38.56$4.88
LENZ Therapeutics, Inc.LENZ$3M69.9k sharesSellAug 15, 2025$39.50$4.88
LENZ Therapeutics, Inc.LENZ$1M30.6k sharesSellAug 18, 2025$38.56$4.88
LENZ Therapeutics, Inc.LENZ$6M145.1k sharesSellAug 15, 2025$39.50$4.88
LENZ Therapeutics, Inc.LENZ$67k1.7k sharesSellAug 26, 2025$39.50$4.88
LENZ Therapeutics, Inc.LENZ$844k21.7k sharesSellAug 26, 2025$38.97$4.88
LENZ Therapeutics, Inc.LENZ$42k1.1k sharesSellAug 25, 2025$39.92$4.88
LENZ Therapeutics, Inc.LENZ$979k24.8k sharesSellAug 25, 2025$39.53$4.88
LENZ Therapeutics, Inc.LENZ$114k2.8k sharesSellAug 22, 2025$40.59$4.88
LENZ Therapeutics, Inc.LENZ$403k10.1k sharesSellAug 22, 2025$40.03$4.88
LENZ Therapeutics, Inc.LENZ$137k3.5k sharesSellAug 26, 2025$39.50$4.88
LENZ Therapeutics, Inc.LENZ$2M44k sharesSellAug 26, 2025$38.97$4.88
LENZ Therapeutics, Inc.LENZ$86k2.1k sharesSellAug 25, 2025$39.92$4.88
LENZ Therapeutics, Inc.LENZ$2M50.3k sharesSellAug 25, 2025$39.53$4.88
LENZ Therapeutics, Inc.LENZ$230k5.7k sharesSellAug 22, 2025$40.59$4.88
LENZ Therapeutics, Inc.LENZ$820k20.5k sharesSellAug 22, 2025$40.03$4.88
LENZ Therapeutics, Inc.LENZ$5.7k132 sharesSellSep 18, 2025$43.30$4.88
LENZ Therapeutics, Inc.LENZ$866k20.1k sharesSellSep 18, 2025$43.00$4.88
LENZ Therapeutics, Inc.LENZ$1M24.4k sharesSellSep 18, 2025$41.59$4.88
LENZ Therapeutics, Inc.LENZ$12k268 sharesSellSep 18, 2025$43.30$4.88
LENZ Therapeutics, Inc.LENZ$2M40.9k sharesSellSep 18, 2025$43.00$4.88
LENZ Therapeutics, Inc.LENZ$2M49.5k sharesSellSep 18, 2025$41.59$4.88
Monte Rosa Therapeutics, Inc.GLUE$57k9.3k sharesSellSep 13, 2024$6.16$23.41
Monte Rosa Therapeutics, Inc.GLUE$96k16k sharesSellSep 12, 2024$6.00$23.41
Monte Rosa Therapeutics, Inc.GLUE$3M541.9k sharesSellSep 11, 2024$6.00$23.41
Monte Rosa Therapeutics, Inc.GLUE$7M1.1M sharesSellSep 20, 2024$6.53$23.41
Monte Rosa Therapeutics, Inc.GLUE$147k15.6k sharesSellOct 29, 2024$9.41$23.41
Monte Rosa Therapeutics, Inc.GLUE$475k52.3k sharesSellOct 29, 2024$9.08$23.41
Monte Rosa Therapeutics, Inc.GLUE$869k90k sharesSellOct 28, 2024$9.66$23.41